Benefits
Hypochlorhydria correction in deficient individuals
An estimated 20–30% of adults over 60 have hypochlorhydria (low stomach acid), with prevalence increasing with age, PPI use, and autoimmune gastritis. Symptoms include bloating, fullness after small meals, undigested food in stool, mineral deficiencies (iron, B12, calcium, magnesium), and increased food sensitivities. Betaine HCl supplementation can directly correct this in deficient individuals — a 2013 study (Yago et al.) demonstrated betaine HCl effectively re-acidifies the stomach to physiologic pH 1–2 in fasted achlorhydric patients.
Improved protein digestion and amino acid absorption
Adequate stomach acid is essential for activating pepsinogen to pepsin, denaturing dietary proteins, and creating the acidic environment necessary for downstream pancreatic enzyme function. In hypochlorhydric individuals, protein digestion is significantly impaired — leading to undigested protein reaching the small intestine and colon. Betaine HCl + pepsin restores this function, improving amino acid absorption.
Mineral absorption improvement (iron, zinc, calcium)
Many minerals require acidic stomach pH for solubilization and absorption — particularly non-heme iron, zinc, calcium, and magnesium. Hypochlorhydric individuals frequently develop deficiencies in these minerals despite adequate intake. PPI use is now well-documented to cause increased risk of osteoporosis, B12 deficiency, and iron deficiency — all linked to acid suppression. Betaine HCl can improve mineral absorption in this context.
Reduced food sensitivities and post-meal symptoms (functional medicine context)
In functional medicine practice, hypochlorhydria is associated with broader 'leaky gut' and food sensitivity patterns. Theoretical: incomplete protein digestion in the stomach allows larger peptides to reach the small intestine, where they may trigger immune reactions. Betaine HCl supplementation in this context aims to improve overall protein digestion and reduce immune-stimulatory peptide passage. Evidence is largely clinical/anecdotal rather than RCT-validated.
Mechanism of action
Stomach acidification for protein denaturation
Betaine HCl dissolves in stomach contents, releasing hydrochloric acid that lowers gastric pH. The acidic environment denatures protein structures (unfolding tertiary and quaternary structure), making proteins accessible to pepsin and other proteases. Without adequate pH, proteins remain partially folded and resistant to enzymatic cleavage.
Pepsinogen activation to pepsin
Pepsinogen (the inactive precursor) is converted to active pepsin only at low gastric pH (<5). Hypochlorhydria fails to fully activate pepsinogen, dramatically reducing protein digestion capacity. Betaine HCl provides the acidity needed for this activation cascade. Supplemental pepsin in the same product directly provides this activity, complementing acidification.
Antimicrobial barrier restoration
Stomach acid is a primary barrier against ingested bacteria, viruses, parasites, and fungi. Hypochlorhydria allows enteric pathogens (Salmonella, Campylobacter, parasites) to survive gastric transit and colonize the small intestine — contributing to small intestinal bacterial overgrowth (SIBO), gastroenteritis susceptibility, and gut dysbiosis. Betaine HCl restores this protective acid barrier.
Lower esophageal sphincter tone (controversial)
Some research suggests adequate stomach acid maintains lower esophageal sphincter (LES) tone via gastrin signaling — potentially explaining the paradoxical observation that some GERD/reflux is associated with low rather than high acid. This mechanism is still debated; betaine HCl should not be used by individuals with active GERD or LES dysfunction without medical guidance.
Clinical trials
Pilot study evaluating betaine HCl-induced gastric acidification in 6 healthy volunteers made achlorhydric with rabeprazole. Subjects received 1,500 mg betaine HCl orally; intragastric pH measured continuously. (Mol Pharm)
6 healthy volunteers with drug-induced achlorhydria.
Betaine HCl 1,500 mg reduced gastric pH from baseline >5 to <2 within 6 minutes; acidification lasted approximately 73 minutes (median). Demonstrates that betaine HCl can transiently re-acidify the stomach in PPI-induced hypochlorhydria — relevant for absorption of pH-dependent oral drugs and potentially for natural hypochlorhydria. Note: this is a small mechanistic study, not a clinical efficacy trial.
Review and pooled analysis examining the association between hypochlorhydria (medication-induced, primarily proton pump inhibitor use) and small intestinal bacterial overgrowth (SIBO). (Lo &, Clin Gastroenterol Hepatol; or related reviews)
Pooled across observational and case-control studies.
Strong association between PPI use, hypochlorhydria, and SIBO development. Note: betaine HCl was not directly evaluated as treatment for SIBO in this body of evidence — the rationale for betaine HCl in this context is mechanistic (restoring gastric acid), not directly clinical trial-supported. Clinicians using betaine HCl for digestive support should be transparent that the evidence is indirect.